Skip to main content
Cosmetics Manufacturing

MoCRA for Beauty Brands: Registration, Listing and Safety Records

For U.S.-market cosmetics, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) adds facility-registration, product-listing, safety-substantiation, adverse-event, records-access and other duties to the existing federal cosmetics framework. Which party files depends on its role and any exemption. A registration or listing number is not FDA approval. Verify each SKU, facility and label before launch.

Quick Answer

MoCRA is a 2022 U.S. law that amended the Federal Food, Drug, and Cosmetic Act. For a typical brand, the central tasks are to identify the responsible person and manufacturing/processing facilities, determine whether any small-business exemption applies, maintain adequate safety substantiation, provide a usable U.S. adverse-event contact on the label, handle serious adverse-event reports within the statutory window, retain required records, and coordinate required facility registrations and product listings. Product classification and supply-chain roles matter; a private-label contract alone does not decide responsibility.

This guide is an operational overview, not a product-specific legal opinion. It reflects FDA material checked on October 9, 2026. FDA guidance describes the agency’s current thinking; the statute and regulations control.

Who Has Which MoCRA Role?

MoCRA distinguishes the responsible person from the facility owner or operator. The responsible person is the manufacturer, packer or distributor whose name appears on the cosmetic product label. A facility registration obligation generally falls on the person who owns or operates a facility that manufactures or processes a cosmetic product for U.S. distribution, unless an exemption applies. One business can occupy more than one role, and more than one business may be involved in the same product’s compliance chain.

For private-label products, do not assume that the factory handles all duties or that the brand handles none. Review the actual label, contractual roles, facility activities, importer arrangements and product category. If the brand’s name appears on the label as the distributor or manufacturer, it may be the responsible person even when another company makes the product.

MoCRA Requirement Map

WorkstreamMain accountable partyPractical actionEvidence to retain
Facility registrationOwner/operator of a covered manufacturing or processing facilityDetermine each covered facility and submit/renew registration if requiredFacility identity, FEI, submission and renewal record
Product listingResponsible personList each marketed cosmetic product and required ingredient information; update annuallySKU-to-listing map, submission confirmation and ingredient version
Safety substantiationResponsible personHold adequate evidence that the finished cosmetic is safe under labeled and reasonably foreseeable useFormula, toxicological rationale and relevant test/data records
Serious adverse eventsResponsible personProvide a functioning label contact and report qualifying U.S. serious events within 15 business daysIntake, investigation, report and follow-up records
Records accessResponsible person and other holders of covered recordsOrganize covered safety and adverse-event records so they can be produced when FDA lawfully requests accessControlled, traceable product files
GMPManufacturing/processing operations and parties responsible for themUse documented controls appropriate to the product and monitor FDA rulemakingProcedures, batch records, training and deviation records

This map is a planning tool, not a replacement for reviewing the statutory definitions and exemptions. FDA says covered facility registrations must be renewed every two years, while a responsible person must provide updates to product listings annually. The FDA’s Cosmetics Direct portal added registration-status and renewal-date fields in February 2026. FDA registration and listing page

Step 1: Map Your Products, Facilities and Responsible Person

Start with a SKU list, not with a generic “FDA compliant” certificate request. For every U.S.-market product, record its brand and marketed name, dosage form, intended use, ingredient formula version, label version, responsible person, manufacturer/processor, facility address and importer or distributor where relevant. Link each SKU to its exact finished-product identity and manufacturing site.

Ask the manufacturer to identify each site that manufactures or processes the product and confirm the facility’s FDA Establishment Identifier (FEI), if applicable. Keep the exact legal entity and site address; a corporate group name alone is not a facility map.

Then review the label. The name on the label helps determine the responsible person, and the cosmetic label must include a domestic address, domestic phone number or electronic contact information through which the responsible person can receive adverse-event reports. An overseas brand or responsible person should design a contact process that consumers can actually use and that staff monitor.

Step 2: Check Small-Business Exemptions Carefully

MoCRA exempts certain small businesses from facility registration and product-listing requirements. FDA’s materials describe a statutory sales threshold based on average gross annual U.S. sales of cosmetic products for the previous three-year period, adjusted for inflation. This is not a blanket exemption from every MoCRA duty, and the legal definition includes details and exclusions that a company should check against its own facts.

The small-business exemption does not apply to facilities or responsible persons for certain product types: cosmetics that regularly contact the eye’s mucous membrane under customary use, injected cosmetics, products for internal use, and products intended to change appearance for more than 24 hours when consumer removal is not part of customary use. These exceptions can matter for products near the cosmetic/drug boundary or for long-wear claims. Confirm classification and use conditions rather than relying on the product’s marketing name.

FDA does not issue small-business exemption certificates. A manufacturer or brand should document its analysis, supporting sales information and product-category review internally. When eligibility is uncertain, obtain qualified regulatory advice before deciding not to register or list.

Step 3: Coordinate Facility Registration and Product Listing

Facility registration and product listing are separate submissions with different accountable parties. A covered facility owner/operator registers the facility and renews the registration biennially. The responsible person lists each marketed cosmetic product, including required ingredient information, and submits annual updates. If a formula, product identity, facility or other listing field changes, document what changed and when; do not let an annual update process become an excuse to leave inaccurate information in the meantime.

FDA offers Cosmetics Direct for electronic submissions. Its February 2026 materials describe an abbreviated renewal option when the facility information has not changed, and the portal shows registration status and renewal date. Establish an account owner, backup contact and calendar reminder. Keep the submission confirmation, date and submitted version in the product compliance file.

FDA expressly says registration and listing are not an approval program or promotional tool and does not issue certificates verifying compliance. Do not assume a contractor has listed a branded SKU or present a listing number as FDA approval.

Step 4: Build Safety Substantiation Around the Finished Product

MoCRA requires the responsible person to ensure and maintain records supporting adequate safety substantiation. FDA’s existing safety materials explain that the conclusion should consider the product’s composition, available toxicological data and other relevant evidence under customary use and reasonably foreseeable misuse. The correct evidence depends on the formula, exposure route, packaging, target user and intended use; a single generic test panel is not a universal legal checklist.

A practical file may include the formula and ingredient specifications; supplier safety information; exposure and use assumptions; toxicological review; microbiological risk assessment and relevant results; stability and packaging-compatibility evidence; and any finished-product testing used to resolve identified uncertainties. Record the rationale for selecting or not selecting particular tests. Retain the approved label and claims alongside the evidence because those define how consumers are directed to use the product.

An ingredient-level review does not automatically settle the safety of the finished formula. A change in concentration, fragrance, preservative, package, use area or directions can change the assessment. Use change control to trigger a documented review, and make sure the evidence corresponds to the production formula and marketed package.

Step 5: Set Up Serious Adverse-Event Reporting Before Launch

The responsible person must report a serious adverse event associated with a cosmetic product used in the United States to FDA within 15 business days after receipt. If new and material medical information arrives within one year after the initial report, the responsible person must submit that information within 15 business days after receipt. FDA describes serious events in terms including death, a life-threatening experience, inpatient hospitalization, persistent or significant disability or incapacity, congenital anomaly or birth defect, or an intervention needed to prevent such an outcome.

Before launch, put the required contact information on the label and test the consumer intake route. Train customer service, marketplace support and distributors to escalate possible events immediately. Capture the product, lot, reporter, event description, timing, medical information and follow-up attempts; route suspected serious cases to the responsible person without waiting for a monthly quality meeting. Use FDA Form 3500A or the agency’s current electronic reporting route as applicable, and include the required product label copy.

FDA’s page on reporting cosmetics complaints describes the 15-business-day clock and one-year follow-up rule. Non-serious complaints still matter operationally: trend them, investigate quality signals and preserve related records even when an FDA serious-event report is not required.

Step 6: Keep Records Organized and Inspection-Ready

Create one controlled file per product and link it to its manufacturing site. Include the current formula and version history, raw-material and finished-product specifications, manufacturing and quality records, safety assessment, packaging and stability rationale, label/claims approvals, facility and listing submissions, adverse-event intake and follow-up records, deviations, complaints and corrective actions. Define retention periods based on the applicable MoCRA provision and other laws; some small businesses have different periods for certain records. Do not invent one universal retention period for every document.

Agree with suppliers on record access, response times, batch data, safety support and change notices before launch. Keep revision trails and avoid making email attachments the only copy of critical evidence.

Manufacturer-Side Handoff: Questions to Put in the RFQ

Ask each candidate manufacturer for the proposed legal entity and site, FEI or registration details where applicable, product and ingredient information for listing, formula and packaging change-control procedures, batch and quality records, limits of supplied safety data, complaint escalation route and record-response time. Name who can approve changes.

The brand should own label, intended-use and consumer-contact decisions with qualified regulatory input. A manufacturer’s records support the process, but its registration does not establish FDA approval or complete the responsible person’s obligations. Put handoffs in writing.

Common MoCRA Mistakes and Procurement Risks

  1. Treating a registration number as FDA approval. FDA says registration and listing are not approval or certification.
  2. Assuming the factory owns every duty. Filing responsibility depends on the statutory role, label and activity.
  3. Using the small-business exception without checking product exclusions. Eye-mucous-membrane, injected, internal-use and certain long-wear products are excluded from that exception.
  4. Keeping safety data only at the contract manufacturer. The responsible person needs access to its supporting records and an effective way to retrieve them.
  5. Leaving an unmonitored contact route on the label. It can delay escalation and reporting.
  6. Reusing a submission after a formula or facility change. Maintain a SKU-to-formula-to-facility version trail and assess update duties.
  7. Buying a generic “MoCRA certificate.” FDA states it does not issue certificates or verification documents for registration/listing compliance.

Frequently Asked Questions

Does MoCRA require FDA to approve cosmetics before sale?

No. FDA generally does not preapprove cosmetics or their ingredients, except for color additives and certain other legally specified cases. MoCRA created additional duties, including facility registration and product listing for covered parties; those submissions do not mean FDA approved a product.

Who lists a private-label cosmetic with FDA?

The responsible person submits product listings. That means the manufacturer, packer or distributor whose name appears on the label under the applicable definition. Confirm the label and commercial roles for each product; do not assume the factory or brand is automatically responsible in every arrangement.

Does a small beauty brand need to register and list?

Some small businesses are exempt from facility registration and product-listing requirements if they meet the statutory definition. The exemption has product-category exclusions and does not remove every other MoCRA duty. Review current FDA materials and qualified advice against your sales, product type and operations.

How often are facility registration and product listing updated?

Required facility registrations are renewed every two years. Responsible persons provide updates to product listings annually. Track changes between renewals and annual updates, then confirm whether an earlier submission is required for the particular change.

What is the FDA serious adverse-event reporting deadline?

The responsible person must report a qualifying serious adverse event within 15 business days after receipt. New and material medical information received within one year after the initial report has a separate 15-business-day reporting deadline after receipt.

What is a practical next step for a brand?

Map each SKU to its label, responsible person, manufacturer, site and formula version. Then request the records needed to check registration/listing duties, safety support and complaint handling.

Conclusion: Turn MoCRA Into a Product-Level Checklist

MoCRA work becomes manageable when each SKU has a named responsible person, mapped site, documented exemption decision, current listing and label, retrievable safety evidence and tested adverse-event route. For market-specific documentation support, see INHI’s cosmetics compliance and documentation capabilities. Browse the INHI cosmetics manufacturing insights hub for related planning guides, including private-label self-tanning format choices and DHA self-tanner formulation decisions. Have qualified regulatory support confirm which obligations apply to your product and business structure.

Planning a U.S. cosmetics launch? Share your product brief with INHI to discuss the manufacturing information and documentation your development plan should request. Contact INHI about a cosmetics project.

Sources and References

Last updated: October 9, 2026.

From Insight to Execution

Explore Our Capabilities

Build With INHI

Ready to Develop Your Skincare Brand?

Share your product idea, target market, formula requirements, packaging preferences, and estimated order quantity with our OEM/ODM team.

Start Your Project